We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 41-60 of 1,462 results
  1. Safely disposing unused and unwanted prescription and over-the-counter medications: a public health, housing, and safety partnership in Framingham, MA

    Background

    The improper disposal of unused drugs can harm the environment and living beings. Programs such as drug take-back bins encourage people to...

    Tamara Vehige Calise, Sarah Levin Martin, Chloe Wingerter in Journal of Pharmaceutical Policy and Practice
    Article Open access 01 March 2022
  2. Geriatric Health Services: Evidence and Impact in Pharmacy and Pharmaceutical Public Health in Low-to-Middle-Income Countries

    Aging is a natural process and a special concern globally because it may necessitate special care for the geriatric population. Older age may be...
    Reference work entry 2023
  3. Individualize treatment when prescribing medical cannabis to older patients as efficacy data remains limited

    There is a growing interest in the use of cannabis for medical purposes, especially in older patients who experience pain, sleep difficulties, mood...

    Article 23 July 2019
  4. Accelerating the Availability of Medications to Pediatric Patients by Optimizing the Use of Extrapolation of Efficacy

    Improving pediatric therapeutic development is a mission of universal importance among health authorities, pharmaceutical companies, academic...

    Allison Dunn, Dawoon Jung, ... Jogarao V. S. Gobburu in Therapeutic Innovation & Regulatory Science
    Article 26 April 2022
  5. Monitor growth changes from central nervous system stimulants in patients with attention-deficit/hyperactivity disorder

    CNS stimulants used in the management of attention-deficit/hyperactivity disorder (ADHD) may suppress appetite, and thus growth. In randomised...

    Caroline Fenton, Arnold Lee in Drugs & Therapy Perspectives
    Article 30 June 2022
  6. Antibiotic utilization pattern in treatment of acute diarrheal diseases: the case of Hiwot Fana Specialized University Hospital, Harar, Ethiopia

    Background

    The vast majority of acute diarrheal diseases are self-limiting and do not require treatment on a regular basis. Empirical antibiotics...

    Beyene Dereje, Shegaye Yibabie, ... Alemayehu Megersa in Journal of Pharmaceutical Policy and Practice
    Article Open access 10 May 2023
  7. Evidence of the Impact of Interventions to Prevent Obesity

    Obesity has become a major global health challenge. Urgent global action and strong leadership is needed to help countries more effectively intervene...
    Reference work entry 2023
  8. Current and emerging immunobiologic therapies for atopic dermatitis

    Atopic dermatitis (AD) is a chronically relapsing inflammatory skin disease with a multifactorial etiology that affects up to 20% of children and up...

    Hemali Shah, Francelia J. Eckembrecher, ... Keyvan Nouri in Drugs & Therapy Perspectives
    Article Open access 13 June 2024
  9. When a neglected tropical zoonotic disease emerges in non-endemic countries: need to proactively fill the unveiled knowledge gaps towards human monkeypox among the Lebanese population

    Introduction

    The ongoing multi-country outbreak of monkeypox (MPX) that emerges in non-endemic areas is a rare and unprecedented event that has...

    Dalal Youssef, Edmond Abboud, ... Janet Youssef in Journal of Pharmaceutical Policy and Practice
    Article Open access 07 March 2023
  10. Nirmatrelvir plus ritonavir in COVID-19: a profile of its use

    Oral nirmatrelvir plus ritonavir (Paxlovid ) is an effective treatment option for coronavirus disease 2019 (COVID-19), the illness caused by severe...

    Hannah A. Blair in Drugs & Therapy Perspectives
    Article 06 December 2022
  11. A closer look at the 2019 Beers criteria

    Increased use of potentially inappropriate medications (PIMs) is one of the major issues arising in older adults. The use of PIMs has been found to...

    Rishabh Sharma, Malika Arora, ... Parveen Bansal in Drugs & Therapy Perspectives
    Article 04 January 2020
  12. Extrapolation as a Default Strategy in Pediatric Drug Development

    Pediatric drug development lags adult development by about 8 years (Mulugeta et al. in Pediatr Clin 64(6):1185–1196, 2017). In such context, many...

    Margaret Gamalo, Christina Bucci-Rechtweg, ... Ron Portman in Therapeutic Innovation & Regulatory Science
    Article 10 January 2022
  13. COVID-19 and diabetes in 2020: a systematic review

    Attempts were made to review the literature on diabetic patients who experience complications when they contract COVID-19, and to determine whether...

    Farideh A. Javid, Fadi Abdul Waheed, ... Radi Haloub in Journal of Pharmaceutical Policy and Practice
    Article Open access 09 March 2023
  14. Frailty and rate of fractures in patients initiating antihypertensive medications: a cohort study in primary care

    Background

    Treatment for hypertension improves cardiovascular outcomes. Frailty may be present in older people treated for hypertension, but...

    Marc F. Österdahl, Sarah-Jo Sinnott, ... Angel Wong in Drugs & Therapy Perspectives
    Article 15 January 2022
  15. Olopatadine/mometasone combination nasal spray in allergic rhinitis: a profile of its use

    Olopatadine/mometasone furoate combination nasal spray (Ryaltris ® ; referred to hereafter as olopatadine/mometasone), a convenient fixed-dose...

    Yvette N. Lamb in Drugs & Therapy Perspectives
    Article 27 September 2020
  16. Status of Planned and Ongoing Paediatric Trials Investigating COVID-19 Vaccines: A Cross-Sectional Study of Paediatric Clinical Trials Planned in Agreed PIPs and/or Registered in Clinical Trial Databases

    Background

    The immune system matures throughout childhood; therefore, evidence about the safety and efficacy of vaccines for the prevention of...

    Helle Christiansen, Steffen Thirstrup, Christine Erikstrup Hallgreen in Therapeutic Innovation & Regulatory Science
    Article Open access 07 February 2022
  17. Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics

    The use of master protocols allows for innovative approaches to clinical trial designs, potentially enabling new approaches to operations and...

    Yimei Li, Robert Nelson, ... **g**g Ye in Therapeutic Innovation & Regulatory Science
    Article Open access 23 April 2024
  18. Differences in healthcare service utilization in patients with polypharmacy according to their risk level by adjusted morbidity groups: a population-based cross-sectional study

    Background

    Patients with polypharmacy suffer from complex medical conditions involving a large healthcare burden. This study aimed to describe the...

    Jaime Barrio-Cortes, Beatriz Benito-Sánchez, ... Tomás Gómez-Gascón in Journal of Pharmaceutical Policy and Practice
    Article Open access 28 November 2023
  19. Quantifying Clinical Trial Diversity in Pivotal Registration Trials of FDA Novel Drug Approvals

    Background

    Health care inequity includes the lack of adequate representation of various populations in clinical trials. Government, academic and...

    Muhammed Y. Idris, William E. Fitzsimmons, Priscilla Pemu in Therapeutic Innovation & Regulatory Science
    Article 23 October 2023
  20. Comparison between European Medicines Agency and US Food and Drug Administration in Granting Accelerated Marketing Authorizations for Covid-19 Medicines and their Utilized Regulations

    Background

    Prompted by the Covid-19 pandemic and the need to ensure timely and safe access to medicines during a pandemic, the aim of this study was...

    Marina Ghadanian, Ellen Schafheutle in Therapeutic Innovation & Regulatory Science
    Article Open access 20 October 2023
Did you find what you were looking for? Share feedback.